Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Oxford Nanopore Technologies
Breakthrough algorithm enables partially phased, near telomere-to-telomere assembly using standard Oxford Nanopore Simplex reads
April 18, 2025
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore Expands Compatible Products Programme and Strengthens Multi-Omics Ecosystem
April 14, 2025
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore and UK Biobank to create world’s first epigenetic dataset targeting the causes of cancer, dementia, complex disease
November 26, 2024
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK
November 05, 2024
From
Oxford Nanopore Technologies
Via
Business Wire
Singapore’s National Precision Medicine (NPM) Programme Engages Oxford Nanopore to Advance Understanding of the Genetics of Singapore’s Multi-Ethnic Population
August 04, 2024
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore Technologies and Plasmidsaurus Announce Strategic Collaboration to Advance Plasmid Sequencing
July 23, 2024
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore Technologies Collaborates With Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine
May 22, 2024
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore launches PromethION 2 Integrated into open early access
March 07, 2024
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore Technologies and Fabric Genomics Collaborate to Launch an Integrated Whole-Genome Sequencing Solution to Advance the Future of Paediatric Patient Care
October 31, 2023
From
Oxford Nanopore Technologies
Via
Business Wire
Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders
October 19, 2023
From
Oxford Nanopore Technologies
Via
Business Wire
The University of Queensland and Oxford Nanopore Technologies Team up to Accelerate Research Into Quality Control Testing for mRNA Vaccines
September 21, 2023
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore announces education collaboration with Cold Spring Harbor DNA Learning Center and launches pilot accessible sequencing education programme
August 24, 2023
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore Technologies and Geneyx Announce the First Scalable Software Solution to Advance the Future Clinical Use of Nanopore Sequencing
June 09, 2023
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore and 4bases Announce Collaboration to Combine Nanopore Sequencing Devices and 4bases Kits to Support Rapid, High-accuracy Analyses in Human and Cancer Genetics, with a First Target of Same-day BRCA1 and BRCA2 Analysis
March 20, 2023
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore Technologies and Cyclomics begin developer testing on non-invasive method for accurate and fast detection of molecules associated with cancer
March 16, 2023
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore Technologies Teams up With UPS Healthcare to Accelerate Delivery of New-Generation DNA Sequencing Technology to More Customers in Locations Across Asia Pacific
February 16, 2023
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore Technology Update Shows Consolidations and Updates for a Single, High-performance Sequencing Platform
December 07, 2022
From
Oxford Nanopore Technologies
Via
Business Wire
Oxford Nanopore Opens Genomics Market With PromethION 2 Solo: The World’s First Portable, High Yield Sequencer Providing Comprehensive DNA Analysis for Anyone, Anywhere
October 24, 2022
From
Oxford Nanopore Technologies
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.